Gastroenterology Advisor Jessica Nye, PhD January 25, 2024 Read the full release >> Key Point: Although a proof-of-concept study, the findings illustrate AI’s potential for creating phenotypic representations of real-world data that can help identify rapid fibrosis progression in MASH. Detailed real-world data from organ systems may be used to stratify patient risk for rapid[…]
Dr. Carl Marci to present on utilizing real-world data for multiple sclerosis research to improve understanding and treatment of the disease February 27, 2024 09:00 AM Eastern Standard Time –(BUSINESS WIRE)–OM1: WHAT: OM1, a leading real-world data, AI, and technology company with a focus on chronic diseases, today announced an upcoming poster presentation hosted by Dr.[…]
Dermatology Times February 20, 2024 Read the full article >> “Rare Disease Day raises awareness for the 300 million people living with rare diseases around the world and their families and carers. Relatively common symptoms can hide underlying rare diseases, leading to misdiagnosis and [delayed] treatment,” writes the Rare Disease Day organization.1 Rare Disease Day has[…]
Healthcare IT Today January 15, 2024 Read the full article >> Joseph Zabinski, Ph.D., Managing Director, AI & Personalized Medicine at OM1 The Anti-Prediction of AI in 2024: The healthcare industry likes to compare artificial intelligence (AI) to a standard of perfection – we want it to get the answer ‘right’ every time, and sometimes, we’ll[…]
OM1 is reimagining real-world evidence with the development of large, electronically connected networks of clinicians in key specialty areas. This ebook explores powerful insights, analyses, and use cases that leverage AI and data science from OM1’s Neuroscience Specialty Network. View ebook >>
